خانه › بیماری کرون › نیویورک › New York City
آزمایش‌های بالینی بیماری کرون در New York City، NY
35 مطالعه برای بیماری کرون در مراکز New York City (در شعاع حدود ۳۰ مایل) در جستجوی شرکت‌کننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
در حال جذب شرکت‌کنندهمرحله 2
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
در حال جذب شرکت‌کنندهمرحله 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
در حال جذب شرکت‌کنندهمرحله 3
- New York Gastroenterology Associates ( Site 0253), New York
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
در حال جذب شرکت‌کنندهمرحله 3
- NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
- Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
- New York Gastroenterology Associates ( Site 5013), New York
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
در حال جذب شرکت‌کنندهمرحله 4
- New York Gastroenterology Associates, New York
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 2
- Northwell Health-Lenox Hill Hospital /ID# 265527, New York
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 2
- Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- New York Gastroenterology Associates, New York
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 2/3
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Weill Cornell Medical College, New York
- Lenox Hill Hospital, New York
- و 1 مورد دیگر
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
در حال جذب شرکت‌کنندهمرحله 3
- New York Gastroenterology Associates, New York
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Manhattan Clinical Research, LLC-Site Number: 8400069, New York
- NYU Langone Health-Site Number: 8400091, New York
- Columbia University Medical Center-Site Number: 8400138, New York
- و 2 مورد دیگر
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- NYU Langone Health-Site Number: 8400091, New York
- Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
- New York Gastroenterology Associates-Site Number: 8400009, New York
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Icahn School of Medicine at Mount Sinai /ID# 254880, New York
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
در حال جذب شرکت‌کنندهمرحله 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 4
- NYU Langone Health, New York
Standardized Microbiota Transplant Therapy in Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 2
- NYU Langone Health, New York
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- New York Gastroenterology Associates, New York
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center/New York Presbyterian, New York
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Weill Cornell Medicine, New York
Behavioral Therapy for Crohn's Disease
در حال جذب شرکت‌کننده
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
در حال جذب شرکت‌کننده
- NYU Langone Health, New York
- Cornell University, New York
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- New York University, New York
Low Dose IL-2 for the Treatment of Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 1/2
- Mount Sinai, New York
Autologous Stem Cell Transplant for Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 2
- Icahn School of Medicine at Mount Sinai, New York
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Icahn School of Medicine at Mount Sinai /ID# 262216, New York
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
در حال جذب شرکت‌کنندهمرحله 3
- New York Presbyterian Hospital, New York
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 2
- Icahn School of Medicine at Mount Sinai, New York
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 3
- Columbia University Medical Center, New York-Presbyterian Hospital, New York
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 4
- Columbia University Medical Center, New York
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
در حال جذب شرکت‌کننده
- Weill Cornell Medical College, New York
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
در حال جذب شرکت‌کنندهمرحله 2
- Mirador Therapeutics Selected Site, New York
Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ایپذیرش داوطلبان سالم
- Icahn School of Medicine at Mount Sinai, New York
Treatment of Moderate to Severe Refractory Crohn's Disease
در حال جذب شرکت‌کنندهمرحله 1/2
- Mount Sinai Health Systems, New York
Helmsley 3.0: Abbreviated MRE
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- NYU Langone, New York
آزمایش‌های بیماری کرون در سایر شهرها
- Boston, MA19 مطالعه
- Miami, FL19 مطالعه
- Cleveland, OH19 مطالعه
- St. Louis, MO19 مطالعه
- Tyler, TX17 مطالعه
- Orlando, FL17 مطالعه
- Houston, TX17 مطالعه
- Atlanta, GA17 مطالعه
- San Antonio, TX15 مطالعه
- Los Angeles, CA15 مطالعه
- San Diego, CA15 مطالعه
- Colorado Springs, CO13 مطالعه
سایر مطالعات در New York City
- سرطان پستان136 مطالعه
- سرطان ریه غیرسلول کوچک121 مطالعه
- سرطان (همه انواع)109 مطالعه
- سرطان پروستات103 مطالعه
- سرطان متاستاتیک93 مطالعه
- سرطان کولورکتال78 مطالعه
- سرطان تخمدان69 مطالعه
- سرطان ریه60 مطالعه
- میلوم متعدد60 مطالعه
- سرطان لوزالمعده60 مطالعه
- سرطان آندومتر52 مطالعه
- لوکمیه حاد میلویید51 مطالعه
از ClinicalTrials.gov، داده‌ها در تاریخ 6 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم می‌گیرد چه کسانی می‌توانند شرکت کنند.